Correction: TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer.

Xiaojing Cheng Kelong Fan Lin Wang Xiangji Ying Andrew J Sanders Ting Guo Xiaofang Xing Meng Zhou Hong Du Ying Hu Huirong Ding Ziyu Li Xianzi Wen Wenguo Jiang Xiyun Yan Jiafu Ji

Cell Death Dis

Key Laboratory Carcinogenesis and Translational Research (Ministry of Education/Beijing), Division of Gastrointestinal Cancer Translational Research Laboratory, Peking University Cancer Hospital & Institute, Beijing, China.

Published: November 2022

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700721	PMC
http://dx.doi.org/10.1038/s41419-022-05453-w	DOI Listing

Publication Analysis

Top Keywords

correction tfr1

tfr1 binding

binding h-ferritin

h-ferritin nanocarrier

nanocarrier achieves

achieves prognostic

prognostic diagnosis

diagnosis enhances

enhances therapeutic

therapeutic efficacy

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!